about
The Digital Fish Library: using MRI to digitize, database, and document the morphological diversity of fish25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future PerspectivesImproving the performance of phase-change perfluorocarbon droplets for medical ultrasonography: current progress, challenges, and prospects.Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersMolecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agentsHER2 targeted molecular MR imaging using a de novo designed protein contrast agentOpportunities and challenges for digital morphologyProtein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging.New paradigm for management of hepatocellular carcinoma by imaging.Magnetic resonance imaging of ischemia viability thresholds and the neurovascular unit.Lectin conjugates as biospecific contrast agents for MRI. Coupling of Lycopersicon esculentum agglutinin to linear water-soluble DTPA-loaded oligomers.Characterization of tumor microvascular structure and permeability: comparison between magnetic resonance imaging and intravital confocal imaging.Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-M-enhanced MRI: implications for plaque vulnerabilityMagnetic iron oxide nanoparticles for biomedical applications.Relaxivity of gadolinium complexes detected by atomic magnetometry.Micro-CT based experimental liver imaging using a nanoparticulate contrast agent: a longitudinal study in mice.A modular system for the synthesis of multiplexed magnetic resonance probes.Spatially resolved quantification of gadolinium(III)-based magnetic resonance agents in tissue by MALDI imaging mass spectrometry after in vivo MRI.Labeling Human Melanoma Cells With SPIO: In Vitro Observations.Strategies for Target-Specific Contrast Agents for Magnetic Resonance ImagingcRGD peptide-conjugated icosahedral closo-B12(2-) core carrying multiple Gd3+-DOTA chelates for α(v)β3 integrin-targeted tumor imaging (MRI).The detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomain.Photochromically-controlled, reversibly-activated MRI and optical contrast agent.Magnetic nanoparticles and their applications in medicine.Mn₃[Co(CN)₆]₂@SiO₂ core-shell nanocubes: novel bimodal contrast agents for MRI and optical imaging.Usefulness of power Doppler ultrasonography and superparamagnetic iron oxide enhanced magnetic resonance imaging for diagnosis of focal nodular hyperplasia of the liver after treatment of neuroblastoma.Paramagnetic liposome nanoparticles for cellular and tumour imaging.Molecular MRI of atherosclerosis.Technological developments and future perspectives on graphene-based metamaterials: a primer for neurosurgeons.Pre-Hepatectomy Assessment of Bile Transporter Expression by Gadoxetic Acid-Enhanced MRI in a Rat Model of Liver Cirrhosis.Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy.Evaluation of atherosclerotic lesions using dextran- and mannan-dextran-coated USPIO: MRI analysis and pathological findings.Multivalent protein polymer MRI contrast agents: controlling relaxivity via modulation of amino acid sequence.Liver cancer imaging: role of CT, MRI, US and PET.Models of hepatocellular carcinoma and biomarker strategy.Probing T1-T2 interactions and their imaging implications through a thermally responsive nanoprobe.Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent.Differentiating primary hepatic angiosarcomas from hemangiomatosis and epithelioid hemangioendotheliomas using gadoxetic acid-enhanced and diffusion-weighted MR imaging.A design strategy for small molecule-based targeted MRI contrast agents: their application for detection of atherosclerotic plaques.A novel one-step synthesis of Gd3+-incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent.
P2860
Q24810358-0FBBED32-99E7-41AF-9A32-6C31C0AF40A5Q26774810-9204A469-6DAC-4E50-9B95-4AD7B9C52DC9Q26861530-C252DA9F-C416-43C1-9967-2DEDE2E7CA7EQ28235682-9DF5E567-9F5C-492C-9AA5-354EEEFE8929Q28304646-546EBEE0-19F6-43BA-8922-F89A7A03F601Q28477503-F69F37DD-1064-4CE2-AD78-530D2386BB12Q28750265-0A49B10D-E265-475D-8AF4-69C3CB33CE12Q30299954-E2FF8264-1ADB-44C5-91A6-20D59D36C02FQ30448048-7188AA03-2C31-4141-B686-5CE4DBC9D85CQ30634170-AAEF75CD-E001-44DA-8CA0-65B8AEBCB980Q33614876-24723925-DD8D-44FB-851A-B4D9A0C26034Q33627998-CAD75C81-351E-4AA6-9342-0B681ADA325DQ33815784-6AFA7237-991B-4544-BBA8-FBF5FF1AF480Q33852478-60A2F2B5-5B99-4105-A840-F978E79BA128Q33854303-A2A2E852-AD48-4889-B5A4-C82115A7B344Q34044985-0E61BA96-7134-41B7-A3BC-E1BD06346D98Q34913014-F9F7A57F-8A2B-415A-B35A-C7F7D01F50CFQ35562801-653D0623-71B0-4E54-AA4A-F1C38841100CQ35974687-07D181A4-1914-4D32-8767-8CFBF5178F08Q36517070-1A2E326C-2F0B-4F90-9172-FB543CA677B9Q36671358-0C77ACD7-6033-4539-8840-BFE3720C3FF5Q36790262-21EE136D-9A44-4B01-AD6D-D342DC4E3EC0Q36915811-A4739119-98A2-4013-B416-BE3401102FB0Q36917874-7CA1FC90-5FF4-4803-BDC6-987B1735FC34Q37165329-DC5B3147-9E27-497A-A8E0-80676B7D35B5Q37724241-23BCD26F-ECCC-4C97-948C-9C61C9A5BFD0Q37755998-A78D9C9B-E220-4E45-B4C7-01413EBBD794Q38162728-408793C6-394C-4CFA-9BE6-3908D265E0F7Q38183215-3E89B1C3-AD8B-44A4-B372-60DED20751B7Q38409403-A922A2AA-DC3C-4AD5-9DEE-C66E40FB4585Q39216032-5188B49B-7D14-4413-8F02-69E983E45D27Q39343765-141672DD-E62F-4E76-8005-A94EC946434BQ39710738-EBB4CDAC-88C9-434E-9E52-F0F9A815F986Q41872601-2DF128DE-1FC1-4415-A4DA-F32FDC6FEA96Q42872868-EA6E8343-C18B-4644-9416-8411C8368C65Q46327941-878E8C1E-084A-4BDD-A51E-9B6D511297DBQ47785854-F60BBE74-28D9-4662-A32D-E6ED8B6AF55EQ50210190-E6A8FE52-0A3E-40A4-A6BD-AC891B6A3ADBQ51057792-EBAA1F40-9AF0-487E-997C-5CE98C33A644Q51608260-2F0CA5EC-0035-4D11-874F-821B32BAEB26
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tissue-specific MR contrast agents.
@ast
Tissue-specific MR contrast agents.
@en
type
label
Tissue-specific MR contrast agents.
@ast
Tissue-specific MR contrast agents.
@en
prefLabel
Tissue-specific MR contrast agents.
@ast
Tissue-specific MR contrast agents.
@en
P2093
P1476
Tissue-specific MR contrast agents.
@en
P2093
Bernd Misselwitz
Hanns-Joachim Weinmann
Heribert Schmitt-Willich
Wolfgang Ebert
P356
10.1016/S0720-048X(02)00332-7
P577
2003-04-01T00:00:00Z